MOOD-HF: SSRI No Better Than Placebo in Depressed CHF PatientsMOOD-HF: SSRI No Better Than Placebo in Depressed CHF Patients
A new study makes the case for not using escitalopram in CHF patients who are depressed, as there were no differences with placebo in hospitalizations, deaths, or even depression scores. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 25, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Medication and Anxiety
Medication can be an effective approach for managing various types of anxiety such as panic, hyperarousal, and constant worry. However, contrary to popular belief and subtle messages from pharmaceutical companies, medication is far from a cure. In fact, when it comes to “cures” for most psychiatric conditions, the data tends to support psychotherapy.
For example, post-traumatic stress disorder (PTSD) responds very well to psychotherapy, whereas the positive effects of medication are somewhat limited. The same is true for panic disorder. Although certain types of medication are very good at relieving panic sympt...
Source: Psych Central - March 11, 2015 Category: Psychiatry Authors: Bret Moore, PsyD Tags: Anti-anxiety Antidepressants Benzodiazepines Disorders General Medications Panic Disorder anti-anxiety medications Drug Dependency Fear Hyperarousal Sedatives Selective Serotonin Reuptake Inhibitor snri Ssri Substance Abuse Source Type: news
Why The Science Behind Anti-Depressants May Be Completely 'Backwards'
Anti-depressants are the most commonly-prescribed medication in the U.S., with one in 10 Americans currently taking pills like Zoloft and Lexapro to treat depression. But these pharmaceuticals are only fully effective roughly 30 percent of the time, and often come with troublesome side effects.
In a controversial new paper published in the journal Neuroscience & Biobehavioral Reviews, psychologist Paul Andrews of McMaster University in Ontario argues that this failure of medication may be based in a misunderstanding of the underlying chemistry related to depression.
Andrews surveyed 50 years' worth of research supporti...
Source: Science - The Huffington Post - February 28, 2015 Category: Science Source Type: news
Why The Science Behind Anti-Depressants May Be Completely 'Backwards'
Anti-depressants are the most commonly-prescribed medication in the U.S., with one in 10 Americans currently taking pills like Zoloft and Lexapro to treat depression. But these pharmaceuticals are only fully effective roughly 30 percent of the time, and often come with troublesome side effects.
In a controversial new paper published in the journal Neuroscience & Biobehavioral Reviews, psychologist Paul Andrews of McMaster University in Ontario argues that this failure of medication may be based in a misunderstanding of the underlying chemistry related to depression.
Andrews surveyed 50 years' worth of research supporti...
Source: Healthy Living - The Huffington Post - February 28, 2015 Category: Consumer Health News Source Type: news
The Science Behind Anti-Depressants May Be Completely 'Backwards'
Anti-depressants are the most commonly-prescribed medication in the U.S., with one in 10 Americans currently taking pills like Zoloft and Lexapro to treat depression. But these pharmaceuticals are only effective less than 30 percent of the time, and often come with troublesome side effects.
In a controversial new paper published in the journal Neuroscience & Biobehavioral Reviews, psychologist Paul Andrews of McMaster University in Ontario argues that this failure of medication may be based in a misunderstanding of the underlying chemistry related to depression.
Andrews surveyed 50 years' worth of research supporting t...
Source: Healthy Living - The Huffington Post - February 28, 2015 Category: Consumer Health News Source Type: news
The Science Behind Anti-Depressants May Be Completely 'Backwards'
Anti-depressants are the most commonly-prescribed medication in the U.S., with one in 10 Americans currently taking pills like Zoloft and Lexapro to treat depression. But these pharmaceuticals are only effective less than 30 percent of the time, and often come with troublesome side effects.
In a controversial new paper published in the journal Neuroscience & Biobehavioral Reviews, psychologist Paul Andrews of McMaster University in Ontario argues that this failure of medication may be based in a misunderstanding of the underlying chemistry related to depression.
Andrews surveyed 50 years' worth of research supporting t...
Source: Science - The Huffington Post - February 28, 2015 Category: Science Source Type: news
I, Intern: When the Doctor Is on Lexapro
(MedPage Today) -- A pediatric intern manages her mental illness. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 21, 2015 Category: Psychiatry Source Type: news
Exposure to antidepressants during gestation influences anxiety behavior later in life
Courtesy of Anne Andrews
Anne Andrews
About 15 percent of U.S. women suffer from anxiety disorders and depression during their pregnancies, and many are prescribed antidepressants. However, little is known about how their children might be affected by exposure to these medications in the womb.
It’s a vital question because 5 percent of all babies born in the U.S. — more than 200,000 a year — are exposed to antidepressants via transmission from their mothers during gestation.
Now, a UCLA team studying early developmental exposure to two different antidepressants, Prozac and Lexapro, has found that although the two dr...
Source: UCLA Newsroom: Health Sciences - January 13, 2015 Category: Universities & Medical Training Source Type: news
Taking Antidepressants When Pregnant - Effect on Unborn Child
Study of early developmental exposure to antidepressants Prozac and Lexapro in model that mimics third trimester medication exposure (Source: Disabled World)
Source: Disabled World - December 20, 2014 Category: Disability Tags: Pregnancy Source Type: news
Early exposure to antidepressants affects adult anxiety, serotonin transmission
Early developmental exposure to two different antidepressants, Prozac and Lexapro, has been studied by researchers in a mouse model that mimics human third trimester medication exposure. They found that, although these serotonin-selective reuptake inhibiting antidepressants were thought to work the same way, they did not produce the same long-term changes in anxiety behavior in the adult mice. About 15 percent of women in the United States suffer from anxiety disorders and depression during their pregnancies, and many are prescribed antidepressants. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 19, 2014 Category: Science Source Type: news
Early exposure to antidepressants affects adult anxiety and serotonin transmission
(University of California - Los Angeles Health Sciences) Now, a UCLA team has studied early developmental exposure to two different antidepressants, Prozac and Lexapro, in a mouse model that mimics human third trimester medication exposure. They found that, although these serotonin-selective reuptake inhibiting antidepressants were thought to work the same way, they did not produce the same long-term changes in anxiety behavior in the adult mice. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2014 Category: Global & Universal Source Type: news
Street Drug 'Special K' May Offer New Hope For People With Treatment-Resistant Depression
A hallucinogenic drug known on the street as "Special K" offers new hope to those suffering from severe, treatment-resistant depression.
Ketamine, which is derived from phencyclidine (PCP), already has a well-established medical use as a sedative or pain killer. But since 2000, small but high-quality studies have demonstrated its uses as a powerful and fast-acting treatment for major depression.
The growing body of evidence has emboldened doctors to begin prescribing Ketamine for depression, despite the fact that the drug has not been approved for such a use and the long-term effects are still unknown. To address those...
Source: Science - The Huffington Post - December 12, 2014 Category: Science Source Type: news
Anxiety Can Lead to Depression, and Depression Repays the Favor
Anxiety and depression often go hand in hand. Many people who have one will experience the other at some point. In fact, nearly one-half of those diagnosed with depression are also diagnosed with an anxiety disorder. When you miss work, sleep too much or feel sad most of the day nearly every day, you are bound to miss opportunities at work and in life. Your love life may suffer, you may run into financial problems, and while experiencing a deep and overwhelming depression, you may have trouble keeping up with the things that used to be important to you. Then, when the depression begins to lift, you may realize that you hav...
Source: Healthy Living - The Huffington Post - November 21, 2014 Category: Consumer Health News Source Type: news
Escitalopram Cuts MACE Risk in Depressed Patients With ACS
Higher risk of major adverse cardiac events with concurrent depression after acute coronary syndrome (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Cardiology, Family Medicine, Internal Medicine, Nursing, Pharmacy, Psychiatry, Journal, Source Type: news
Escitalopram Reduces Symptoms of Anxiety in Teens With GAD
Increasing CYP2C19 metabolism linked to reductions in escitalopram Cmax, AUC (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Family Medicine, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news
